Clinical Trials in Dallas

Showing 10821-10840 of 17,468 trials

Answer ALS: Individualized Initiative for ALS Discovery

NCT02574390

Creation of a large repository of induced pluripotent stem cells (iPSC), bio-fluid samples (blood and spinal fluid (optional)), and cell lines for ALS gene identification. This will be combined carefully with collected measures of the pattern of the symptoms people with ALS have and how these change over time. People with other motor neuron diseases and healthy controls will be included as comparisons

Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more

Johns Hopkins University1,049 participantsStarted Dec 2015

Los Angeles, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +5 more locations

COMPLETEDPhase 3< 1 mile

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

NCT00699972

The purpose of this study is to evaluate the safety, efficacy and tolerability of perampanel when given as an adjunctive therapy in subjects with refractory partial seizures.

Refractory Partial Seizures

Eisai Inc.390 participantsStarted Apr 2008

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +94 more locations

Answer ALS: Individualized Initiative for ALS Discovery

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Find Trials by Condition in Dallas

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia

The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients

Radiesse® Safety Study For the Treatment of Hands

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol

Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations

A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Study to Evaluate DNL201 in Subjects With Parkinson's Disease

An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma